Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v27-EN Version v10-FR
Language English French
Date Updated 2023-01-03 2022-01-14
Drug Identification Number 02314932 02314932
Brand name LEVOFLOXACIN IN 5% DEXTROSE INJECTION LEVOFLOXACIN IN 5% DEXTROSE INJECTION
Common or Proper name LEVOFLOXACIN IN 5% DEXTROSE INJECTION LEVOFLOXACIN IN 5% DEXTROSE INJECTION
Company Name PFIZER CANADA ULC PFIZER CANADA ULC
Ingredients LEVOFLOXACIN LEVOFLOXACIN
Strength(s) 5MG 5MG
Dosage form(s) SOLUTION SOLUTION
Route of administration INTRAVENOUS INTRAVENOUS INTRAVENOUS INTRAVENOUS
Packaging size 24 x 50 mL bag 24 x 50 mL bag
ATC code J01MA J01MA
ATC description QUINOLONE ANTIBACTERIALS QUINOLONE ANTIBACTERIALS
Reason for shortage Disruption of the manufacture of the drug. Disruption of the manufacture of the drug.
Anticipated start date 2022-06-15
Actual start date 2022-04-06
Estimated end date Unknown
Actual end date 2022-10-26
Shortage status Resolved Anticipated shortage
Tier 3 Status No Yes
Company comments
Health Canada comments